Using Cost-Effectiveness Analysis To Target Cholesterol Reduction
- 16 May 2000
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 132 (10) , 833-835
- https://doi.org/10.7326/0003-4819-132-10-200005160-00012
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient CharacteristicsAnnals of Internal Medicine, 2000
- Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial InfarctionAnnals of Internal Medicine, 2000
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Lowering Risk without Lowering Cholesterol: Implications for National Cholesterol PolicyAnnals of Internal Medicine, 1996
- CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, RevisitedAnnals of Internal Medicine, 1996
- CLINICAL GUIDELINE, PART 1: Guidelines for Using Serum Cholesterol, High-Density Lipoprotein Cholesterol, and Triglyceride Levels as Screening Tests for Preventing Coronary Heart Disease in AdultsAnnals of Internal Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Should We Be Measuring Blood Cholesterol Levels in Young Adults?Published by American Medical Association (AMA) ,1993